I’m not sure how to respond to your post. Hon
Post# of 148155
Honestly, I think you’re putting too much faith in Dr. STJ and overstating his “power” over the FDA based on the initial EIND patients and a short video of him mentioning the FDA was reviewing trial data. I’m not discounting his decision to use LL, his willingness to reach out to the FDA for approval or his education/experience, but I don’t see the power that hour attributing to him.